Literature DB >> 4627787

Immunologic response of cancer patients modified by immunization with tumor vaccine.

L J Humphrey, B Boehm, W R Jewell, O R Boehm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4627787      PMCID： PMC1355451          DOI： 10.1097/00000658-197210000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Induced immunity to cancer cell homografts in man.

Authors:  C M SOUTHAM; A E MOORE
Journal:  Ann N Y Acad Sci       Date:  1958-10-07       Impact factor: 5.691

2.  A new method of active immunisation to autologous human tumour tissue.

Authors:  P L Wolf; J Vazquez; N P Czajkowski; M Rosenblatt
Journal:  Lancet       Date:  1967-10-28       Impact factor: 79.321

3.  Treatment of advanced cancer with active immunization.

Authors:  T J Cunningham; K B Olson; R Laffin; J Horton; J Sullivan
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

4.  Human tumor-specific antigens.

Authors:  I Hellström; G E Pierce; K E Hellström
Journal:  Surgery       Date:  1969-06       Impact factor: 3.982

5.  The presence of delayed hypersensitivity reactions in patients toward cellular extracts of their malignant tumors. 2. A correlation between the histologic picture of lymphocyte infiltration of the tumor stroma, the presence of such a reaction, and a discussion of the significance of this phenomenon.

Authors:  T H Stewart
Journal:  Cancer       Date:  1969-06       Impact factor: 6.860

6.  Carcinoembryonic antigen in patients with different cancers.

Authors:  G Reynoso; T M Chu; D Holyoke; E Cohen; T Nemoto; J J Wang; J Chuang; P Guinan; G P Murphy
Journal:  JAMA       Date:  1972-04-17       Impact factor: 56.272

7.  Effect of tumor vaccines in immunizing patients with cancer.

Authors:  L J Humphrey; D R Murray; O R Boehm
Journal:  Surg Gynecol Obstet       Date:  1971-03
  7 in total
  6 in total

Review 1.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

2.  Immunotherapy: its possible application in the management of large-bowel cancer.

Authors:  G M Mavligit; J U Guttermann; M A Burgess; J F Speer; R C Reed; R C Martin; C M McBride; E M Copeland; E A Gehan; E M Hersh
Journal:  Am J Dig Dis       Date:  1974-11

3.  Clinical value of immunochemotherapy with OK-432 or PS-K for stomach cancer patients.

Authors:  S Fujimoto; M Takahashi; T Minami; H Ishigami; M Miyazaki; K Itoh
Journal:  Jpn J Surg       Date:  1979-09

4.  Critical analysis of treatment of stage II and stage III melanoma patients with immunotherapy.

Authors:  W R Jewell; J H Thomas; J M Sterchi; P A Morse; L J Humphrey
Journal:  Ann Surg       Date:  1976-05       Impact factor: 12.969

Review 5.  Adjuvant treatment of colorectal cancer. Current status and concepts.

Authors:  U F Metzger; B C Ghosh; D L Kisner
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Value of lymphocyte reactivity induced by phytohemagglutinin in the treatment of malignant diseases.

Authors:  S Fujimoto; T Minami; B Itoh; H Ishigami; M Miyazaki
Journal:  Jpn J Surg       Date:  1977-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.